Type Here to Get Search Results !

Pharmacology - Hematological/Oncological (24330074 (Tutorial) QID: 18249)

Correct

A. platelet count

[38%]

B. activated partial thromboplastin time (aPTT)

[48%]

C. international normalized ratio (INR)

[12%]

D. white blood cell (WBC) count

[1%]

Statistics

Difficulty level - Hard
38%of peers got it right
Time taken - 90 s

Subject/Lesson

  • Subject

    Pharmacology
  • Lesson

    Hematological/Oncological

Client Need

  • Test Plan

    Pharmacological and Parenteral Therapies
  • Related Topic

    Adverse Effects/Contraindications/Side Effects/Interactions

Item Type

  • Item Type

    Knowledge/Comprehension

Explanation

Choice A is correct. Enoxaparin is a low molecular weight-based heparin (LMWH). One of the adverse events of enoxaparin is heparin-induced thrombocytopenia (HIT). This severe condition results in a 50% or more decrease in the platelet count while also causing thrombosis. Therefore, it is reasonable to monitor the platelet count after initiating enoxaparin.

Choice B is incorrect. Unlike unfractionated heparin, enoxaparin does not require aPTT monitoring. aPTT is appropriate for monitoring a client receiving unfractionated heparin. An unfractionated heparin dose is titrated for an aPTT of 1.5 to 2 times the control (baseline) value to achieve the treatment effect. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) are inadequate for monitoring Lovenox's anticoagulant effects.

Choice C is incorrect. INR is used to measure the effectiveness of warfarin. INR is not relevant to the use of enoxaparin.

Choices D are incorrect. WBC count would be monitored for an array of indications, such as chemotherapy treatment and bacteremia. This laboratory test is not influenced by enoxaparin.

Related Videos

2 Key Topics

Additional Info

✓ Enoxaparin may be used to treat or prevent venous thromboembolism and acute ST-segment elevation myocardial infarction.

✓ Enoxaparin is advantageous because this medication does not require aPTT monitoring.

✓ Enoxaparin should not be administered to individuals with recent spinal surgery or active gastrointestinal bleeding.

✓ Do not administer Lovenox by intramuscular injection.

✓ Do not expel the air bubble from the prefilled syringes before the injection to avoid the loss of the drug.

✓ The nurse should inject enoxaparin into the client's abdomen and refrain from massaging the area following the administration.

Last Updated - 18 Jun 2024